The membrane transport of flavonoids from Crossostephium chinense across the Caco-2 monolayer

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 1, 2011, Pages 16-24

  Wang, Ying ^a   Wu, Qi ^a   Yang, Xiu Wei ^a   Yang, Xiaoda ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Caco 2; efflux; flavonoids; MRP; selagin

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOMETZGERIN; ATENOLOL; CENTAUREIDIN; FLAVONOID; HISPIDULIN; MULTIDRUG RESISTANCE PROTEIN; QUERCETAGETIN; TRICETIN 3', 4', 5' TRIMETHYLETHER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSSOSTEPHIUM CHINENSE; DRUG DIFFUSION; DRUG PENETRATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MEDICINAL PLANT; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MONOLAYER CULTURE; SELAGINELLA;

BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; SESQUITERPENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650413293     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.735     Document Type: Article

References (40)

1. Wattenberg LW,. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992; 52 (Suppl): 2085S-2091S.
2. Bansal T, Jaggi M, Khar RK, Talegaonkar S,. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Sci 2009; 12: 46-78.
3. van Zanden JJ, Wortelboer HM, Bijlsma S, et al,. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance protein 1 and 2. Biochem Pharmacol 2005; 69: 699-708.
4. Wong IL, Chan KF, Tsang KH, et al,. Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J Med Chem 2009; 52: 5311-5322.
5. An G, Morris ME,. Effects of the isoflavonoid biochanin A on the transport of mitoxantrone in vitro and in vivo. Biopharm Drug Dispos 2010; 31: 340-350. DOI: 10.1002/bdd.717.
6. Hollman PCH, Katan MB,. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother 1997; 51: 305-310.
7. Barve A, Chen C, Hebbar V, Desiderio J, Saw CL, Kong AN,. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats. Biopharm Drug Dispos 2009; 30: 356-365.
8. Walle T,. Absorption and metabolism of flavonoids. Free Radic Biol Med 2004; 36: 829-837.
9. Artursson PA, Karlsson J,. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991; 175: 880-885.
10. Barrington R, Williamson G, Bennett RN, Davis BD, Brodbelt JS, Kroon PA,. Absorption, conjugation and efflux of the flavonoids, kaempferol and galangin, using the intestinal Caco-2/TC7 cell model. J Funct Food 2009; 1: 74-78.
11. Chabane MN, Ahmad AA, Peluso J, Muller CD, Ubeaud G,. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 2009; 61: 1473-1483.
12. Tian XJ, Yang XD, Wang K, Yang XW,. The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O- D -xylopyranosyl-(1→6)- D -glucopyranoside in the human intestinal cell line Caco-2. Pharm Res 2006; 23: 1721-1728.
13. Tian XJ, Yang XW, Yang XD, Wang K,. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 2009; 367: 58-64.
14. Murota K, Shimizu S, Chujo H, Moon JH, Terao J,. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch Biochem Biophys 2000; 384: 391-397.
15. Murota K, Shimizu S, Miyamoto S, et al,. Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: comparison of isoflavonoids and flavonoids. J Nutr 2002; 132: 1956-1961.
16. Morris ME, Zhang SZ,. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 2006; 78: 2116-2130.
17. Walle UK, Galijatovic A, Walle T,. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol 1999; 58: 431-438.
18. Walle UK, French KL, Walgren RA, Walle T,. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: Potential role for MRP2. Res Commun Mol Pathol Pharmacol 1999; 103: 45-56.
19. Evans CR,. Flavonoids and isoflavonoids: Absorption, metabolism, and bioactivity. Life Sci 2003; 36: 827-828.
20. Zou L, Wu Q, Yang XW, Fu DX,. Effects of chemical constituents of Crossostephium chinense on insulin secretion in rat islets in vitro. Zhongguo Zhong Yao Za Zhi 2009; 34: 1401-1405.
21. Li WX, Cui CB, Cai B, Wang HY, Yao XS,. Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells. J Asian Nat Prod Res 2005; 7: 615-626.
22. Nguyen MTT, Awale S, Tezuka Y, Ueda JY, Tran QL, Kadota S,. Xanthine oxidase inhibitors from the flowers of Chrysanthemum sinense. Planta Med 2006; 72: 46-51.
23. Okuyama E, Suzumura K, Yamazaki M,. Pharmacologically active components of Viticis Fructus (Vitex rotundifolia). I. The components having vascular relaxation effects. Nat Med 1998; 52: 218-225. (Pubitemid 28328140)
24. Fu DX, Zou L, Yang XW,. Studies on the chemical constituents from the whole plants of Crossostephium chinense. Nat Prod Res Dev 2008; 20: 265-268.
25. Lennernas H, Palm K, Fagerholm U, Artursson P,. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Int J Pharm 1996; 127: 103-107.
26. Zodl B, Schmid D, Wassler G, et al., Intestinal transport and metabolism of acrylamide. Toxicology 2007; 232: 99-108.
27. Sharom FJ,. The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 1997; 160: 161-175.
28. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y,. Overcoming of vincristine resistance, in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981; 41: 1967-1972.
29. Zhou SF, Li Y, Kestell P, Paxton JW,. Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B 2003; 785: 165-173.
30. Versantvoort CHM, Bagrij T, Wright KA, Twentyman PR,. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer 1995; 63: 855-862.
31. Kavvadias D, Sand P, Youdim KA, et al,. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 2004; 142: 811-820.
32. Van Der Sandt ICJ, Blom-Roosemalen MCM, De Boer AG, Breimer DD,. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 2000; 11: 207-214.
33. Guttman H, Fricker G, Torok M, Michael S, Beglinger C, Drewe J,. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res 1999; 16: 402-407.
34. Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y,. Function and expression of multidrug resistance associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther 2000; 292: 265-270.
35. Litman T, Druley TE, Stein WD, Bates SE,. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58: 931-959.
36. Konig JA, Nies T, Cui Y, Leier I, Keppler D,. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377-394.
37. van Zanden JJ, van der Woude H, Vaessen J, et al,. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 2007; 74: 345-351.
38. Cao F, Zhang H, Guo J, Ping Q,. Mrp2-related efflux of scutellarin in the intestinal absorption in rats. Pharmazie 2008; 63: 75-80.
39. Katayama K, Masuyama K, Yoshioka S, Hasegawa H, Mitsuhashi J, Sugimoto Y,. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. Cancer Chemother Pharmacol 2007; 60: 789-797.
40. Zhang L, Lin G, Kovos B, Jani M, Krajcsi P, Zuo Z,. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 2007; 31: 221-231.